Hansoh Pharmaceutical Group Company Limited (3692.HK)
HKD 18.5
(0.11%)
HKD 18.5
(0.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 10.1 Billion | 9.38 Billion | 9.93 Billion | 8.69 Billion | 8.68 Billion | 7.72 Billion |
| Cost of Revenue | 1.03 Billion | 870.19 Million | 870.38 Million | 803.41 Million | 737.52 Million | 603.1 Million |
| Gross Profit | 9.07 Billion | 8.51 Billion | 9.06 Billion | 7.88 Billion | 7.94 Billion | 7.11 Billion |
| Operating Expenses | 6.23 Billion | 5.83 Billion | 5.96 Billion | 4.95 Billion | 5.12 Billion | 4.84 Billion |
| Selling, General and Administrative Expenses | 4.24 Billion | 4.14 Billion | 4.37 Billion | 3.86 Billion | 4.04 Billion | 3.56 Billion |
| Research and Development Expenses | 2.09 Billion | 1.69 Billion | 1.79 Billion | 1.25 Billion | 1.12 Billion | 881.28 Million |
| Other Expenses | - | -168.23 Million | 99.24 Million | 4.04 Million | 13.5 Million | 24.78 Million |
| Cost and Expenses | 7.26 Billion | 6.7 Billion | 6.83 Billion | 5.75 Billion | 5.86 Billion | 5.44 Billion |
| Operating Income | 2.83 Billion | 2.6 Billion | 2.82 Billion | 2.77 Billion | 2.78 Billion | 2.32 Billion |
| Interest Expense | 66.67 Million | 58.14 Million | 52.81 Million | 1.64 Million | 123 Thousand | 10.91 Million |
| Income Tax Expense | 488.65 Million | 364.68 Million | 587.18 Million | 529.39 Million | 444.18 Million | 406.27 Million |
| Earnings before Tax | 3.76 Billion | 2.94 Billion | 3.3 Billion | 3.09 Billion | 3 Billion | 2.3 Billion |
| Net Income | 3.27 Billion | 2.58 Billion | 2.71 Billion | 2.56 Billion | 2.55 Billion | 1.9 Billion |
| Earnings Per Share Basic | 0.52 | 0.44 | 0.46 | 0.44 | 0.47 | 0.33 |
| Earnings Per Share Diluted | 0.54 | 0.44 | 0.44 | 0.44 | 0.47 | 0.33 |
| Weighted Average Shares Outstanding | 6.27 Billion | 5.91 Billion | 5.92 Billion | 5.87 Billion | 5.47 Billion | 5.7 Billion |
| Weighted Average Shares Outstanding (Diluted) | 6.01 Billion | 5.92 Billion | 5.99 Billion | 5.87 Billion | 5.47 Billion | 5.7 Billion |
| Gross Margin | 0.90 | 0.91 | 0.91 | 0.91 | 0.92 | 0.92 |
| EBIT Margin | 0.42 | 0.31 | 0.31 | 0.34 | 0.34 | 0.32 |
| Profit Margin | 0.32 | 0.28 | 0.27 | 0.30 | 0.29 | 0.25 |
| EBITDA | 4.19 Billion | 2.93 Billion | 3.08 Billion | 2.98 Billion | 2.96 Billion | 2.47 Billion |
| Earnings Before Tax Margin | 0.28 | 0.28 | 0.28 | 0.32 | 0.32 | 0.30 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 6.5 Billion | 10.1 Billion | 5.59 Billion | 4.51 Billion | 9.38 Billion | 4.94 Billion |
| Cost of Revenue | 585.98 Million | 1.03 Billion | 501.33 Million | 531.17 Million | 870.19 Million | 471.29 Million |
| Gross Profit | 5.91 Billion | 9.07 Billion | 5.09 Billion | 3.98 Billion | 8.51 Billion | 4.47 Billion |
| Operating Expenses | 3.27 Billion | 6.23 Billion | 3.4 Billion | 2.86 Billion | 5.83 Billion | 3.18 Billion |
| Selling, General and Administrative Expenses | 2.07 Billion | - | 2.24 Billion | 1.99 Billion | - | 2.17 Billion |
| Research and Development Expenses | 1.19 Billion | - | 1.16 Billion | 929.47 Million | - | 954.27 Million |
| Other Expenses | - | -165.4 Million | - | - | -168.23 Million | - |
| Cost and Expenses | 3.85 Billion | 7.26 Billion | 3.91 Billion | 3.39 Billion | 6.7 Billion | 3.65 Billion |
| Operating Income | 2.64 Billion | 2.67 Billion | 1.68 Billion | 1.04 Billion | 2.6 Billion | 1.37 Billion |
| Interest Expense | - | 66.67 Million | - | - | 58.14 Million | - |
| Income Tax Expense | 392.66 Million | 488.65 Million | 277.61 Million | 211.03 Million | 364.68 Million | 153.53 Million |
| Earnings before Tax | 3.11 Billion | 3.76 Billion | 2.26 Billion | 1.49 Billion | 2.94 Billion | 1.43 Billion |
| Net Income | 2.72 Billion | 3.27 Billion | 1.98 Billion | 1.28 Billion | 2.58 Billion | 1.28 Billion |
| Earnings Per Share Basic | 0.46 | - | 0.30 | 0.22 | - | 0.22 |
| Earnings Per Share Diluted | 0.46 | - | 0.33 | 0.22 | - | 0.22 |
| Weighted Average Shares Outstanding | 5.94 Billion | 5.92 Billion | 6.59 Billion | 5.92 Billion | 5.91 Billion | 5.91 Billion |
| Weighted Average Shares Outstanding (Diluted) | 5.94 Billion | 6.01 Billion | 6.09 Billion | 5.94 Billion | 5.92 Billion | 5.93 Billion |
| Gross Margin | 0.91 | 0.90 | 0.91 | 0.88 | 0.91 | 0.90 |
| EBIT Margin | 0.43 | - | 0.32 | 0.27 | - | 0.31 |
| Profit Margin | 0.42 | 0.32 | 0.36 | 0.29 | 0.28 | 0.26 |
| EBITDA | 2.8 Billion | - | 1.8 Billion | 1.21 Billion | - | 1.55 Billion |
| Earnings Before Tax Margin | 0.41 | 0.27 | 0.30 | 0.23 | 0.28 | 0.28 |
ACONW
WAL-PA
4664
AMC
CPS
002009